which glp 1 is serena williams using How big a deal will GLP-1 drugs (and associated) be? in a Super Bowl ad for a GLP-1 programme. Let that sink in. Not a fringe influencer. Not a before-and-after Tennis legend Serena Williams is

How rare is NAION with GLP-1 meds

a , the number of suicide/self-injury reports for GLP-1RA

J., Cairns, A

A change in that basement membranes rigidity caused by a variation in its COL IV contents could therefore modify the DTC-GSC interface, such as to influence the Delta-Notch interaction (Fig.6ac), and thereby the PZ size

Jessica Baylis, 45, takes Zepbound every few weeks after losing nearly 40 pounds on GLP-1s

Seek urgent medical attention (contact 999 or attend A&E) if you experience: Severe, persistent abdominal pain, particularly if accompanied by fever, vomiting, or inability to pass stools or wind Blood in your stools (red blood or black, tarry stools) Signs of severe dehydration: extreme thirst, dark urine, dizziness, confusion, or reduced urine output Persistent vomiting preventing fluid or medication intake Symptoms suggesting pancreatitis: severe upper abdominal pain radiating to the back, often with nausea and vomiting (if pancreatitis is suspected, stop taking your GLP-1 medication immediately) Right upper abdominal pain with fever, yellowing of skin/eyes, dark urine or pale stools (possible gallbladder problems) Contact NHS 111 or your GP within 24-48 hours if: Diarrhoea persists beyond 7 days without improvement You're passing more than 6 loose stools daily Bowel symptoms are significantly impacting your quality of life, work, or daily activities You're unable to maintain adequate nutrition or hydration You develop new symptoms such as unexplained weight loss (beyond expected therapeutic effect), persistent fever, or night sweats Symptoms worsen rather than improve over time Routine review is appropriate if: Mild to moderate symptoms persist but are manageable You're uncertain whether symptoms are medication-related You wish to discuss dose adjustments or alternative management strategies GLP-1 medications are associated with recognised gastrointestinal risks including pancreatitis, gallbladder disease, and rarely, intestinal obstruction